Be the first to like.

Share

“The polypill concept is very important and it’s surprising that it’s taking so long for people to accept it,” said Dr. Salim Yusuf, director of the Population Health Research Institute at McMaster University in Canada and an expert on cardiac health in poor countries, who was not involved in the Iran study. “This study takes us one step closer.”

Other leading cardiologists consider the approach unethical and dangerous. Because aspirin, statins and blood-pressure drugs all have side effects, they argue, no one should get them without first being assessed for risk factors like high blood pressure, high cholesterol or family history.

“I’m a skeptic of the one-size-fits-all, four-drugs-for-everyone approach,” said Dr. Steven E. Nissen, head of the department of cardiovascular medicine at the Cleveland Clinic. “It runs counter to what most of us in the U.S. consider good medical practice.”

Simple tests, including cholesterol tests that use only a finger prick, are available, he noted.

…continue reading ‘This Daily Pill Cut Heart Attacks by Half. Why Isn’t Everyone Getting It?’

Thumb image via article – AFP – Getty Images

Be the first to like.

Share
New York Times

Tags: , , , , , , , , , , ,

Leave a Reply